FC
CVS icon

FORA Capital’s CVS Health CVS Stock Holding History

FORA Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Buy
150,782
+144,926
+2,475% +$12.9M 1.07% 22
2026
Q1 		$421K Buy
+5,856
New +$451K 0.03% 324
2023
Q2 		– Sell
-134,102
Closed -$9.97M – 405
2023
Q1 		$9.97M Buy
134,102
+90,901
+210% +$7.62M 1% 12
2022
Q4 		$4.03M Buy
+43,201
New +$4.17M 0.65% 34
2021
Q3 		– Sell
-39,447
Closed -$3.29M – 478
2021
Q2 		$3.29M Buy
39,447
+31,950
+426% +$2.62M 0.61% 31
2021
Q1 		$564K Sell
7,497
-23,488
-76% -$1.71M 0.19% 136
2020
Q4 		$2.12M Buy
+30,985
New +$2.02M 0.32% 65
2020
Q3 		– Sell
-18,608
Closed -$1.21M – 713
2020
Q2 		$1.21M Sell
18,608
-7,695
-29% -$485K 0.41% 48
2020
Q1 		$1.56M Buy
26,303
+8,177
+45% +$546K 0.34% 66
2019
Q4 		$1.35M Buy
+18,126
New +$1.27M 0.14% 200

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

FORA Capital's CVS Position: Q2 2026 in Review

FORA Capital increased its CVS Health (CVS) stake by 2,475% in Q2 2026, buying an estimated $12.9M and bringing the position to 150,782 shares worth $15.6M. The position accounts for 1.07% of the portfolio, ranked #22.

FORA Capital first reported a position in CVS in Q4 2019 and has held it in 10 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • FORA Capital held 150,782 shares of CVS Health worth $15.6M as of Q2 2026.
  • FORA Capital bought 144,926 CVS Health shares in Q2 2026, an estimated $12.9M.
  • CVS Health made up 1.07% of FORA Capital's portfolio in Q2 2026, its #22 holding.
  • FORA Capital first reported a position in CVS Health in Q4 2019 and has held it in 10 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.